Medprin Selling General Administrative from 2010 to 2025
| 301033 Stock | 47.24 1.91 3.89% |
Selling General Administrative | First Reported 2010-12-31 | Previous Quarter 61.8 M | Current Value 39.6 M | Quarterly Volatility 21 M |
Check Medprin Regenerative financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medprin Regenerative's main balance sheet or income statement drivers, such as Tax Provision of 6.1 M, Interest Income of 2.3 M or Selling General Administrative of 39.6 M, as well as many indicators such as . Medprin financial statements analysis is a perfect complement when working with Medprin Regenerative Valuation or Volatility modules.
Medprin | Selling General Administrative |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Other Information on Investing in Medprin Stock
Medprin Regenerative financial ratios help investors to determine whether Medprin Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medprin with respect to the benefits of owning Medprin Regenerative security.